744 related articles for article (PubMed ID: 18336602)
1. Understanding the elements of overactive bladder: questions raised by the EPIC study.
Irwin DE; Abrams P; Milsom I; Kopp Z; Reilly K;
BJU Int; 2008 Jun; 101(11):1381-7. PubMed ID: 18336602
[TBL] [Abstract][Full Text] [Related]
2. The prevalence of clinically meaningful overactive bladder: bother and quality of life results from the population-based FINNO study.
Vaughan CP; Johnson TM; Ala-Lipasti MA; Cartwright R; Tammela TL; Taari K; Auvinen A; Tikkinen KA
Eur Urol; 2011 Apr; 59(4):629-36. PubMed ID: 21306820
[TBL] [Abstract][Full Text] [Related]
3. Is the bladder a reliable witness for predicting detrusor overactivity?
Hashim H; Abrams P
J Urol; 2006 Jan; 175(1):191-4; discussion 194-5. PubMed ID: 16406907
[TBL] [Abstract][Full Text] [Related]
4. National community prevalence of overactive bladder in the United States stratified by sex and age.
Coyne KS; Sexton CC; Vats V; Thompson C; Kopp ZS; Milsom I
Urology; 2011 May; 77(5):1081-7. PubMed ID: 21256571
[TBL] [Abstract][Full Text] [Related]
5. An epidemiological survey of overactive bladder symptoms in Japan.
Homma Y; Yamaguchi O; Hayashi K;
BJU Int; 2005 Dec; 96(9):1314-8. PubMed ID: 16287452
[TBL] [Abstract][Full Text] [Related]
6. Prevalence, risk factors, and impact on health related quality of life of overactive bladder in China.
Wang Y; Xu K; Hu H; Zhang X; Wang X; Na Y; Kang X
Neurourol Urodyn; 2011 Nov; 30(8):1448-55. PubMed ID: 21826714
[TBL] [Abstract][Full Text] [Related]
7. Add-on fesoterodine for residual storage symptoms suggestive of overactive bladder in men receiving α-blocker treatment for lower urinary tract symptoms.
Kaplan SA; Roehrborn CG; Gong J; Sun F; Guan Z
BJU Int; 2012 Jun; 109(12):1831-40. PubMed ID: 21966995
[TBL] [Abstract][Full Text] [Related]
8. The impact of overactive bladder on mental health, work productivity and health-related quality of life in the UK and Sweden: results from EpiLUTS.
Coyne KS; Sexton CC; Kopp ZS; Ebel-Bitoun C; Milsom I; Chapple C
BJU Int; 2011 Nov; 108(9):1459-71. PubMed ID: 21371240
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and effect on health-related quality of life of overactive bladder in older americans: results from the epidemiology of lower urinary tract symptoms study.
Sexton CC; Coyne KS; Thompson C; Bavendam T; Chen CI; Markland A
J Am Geriatr Soc; 2011 Aug; 59(8):1465-70. PubMed ID: 21718275
[TBL] [Abstract][Full Text] [Related]
10. Overactive bladder in Taiwanese women: re-analysis of epidemiological database of community from 1999 to 2001.
Chen YC; Ng SC; Chen SL; Huang YH; Hu SW; Chen GD
Neurourol Urodyn; 2012 Jan; 31(1):56-9. PubMed ID: 21826728
[TBL] [Abstract][Full Text] [Related]
11. Lower urinary tract symptoms in middle-aged women--prevalence and attitude towards mild urinary incontinence: a community-based population study.
Teleman P; Lidfeldt J; Nerbrand C; Samsioe G; Mattiasson A
Acta Obstet Gynecol Scand; 2005 Nov; 84(11):1108-12. PubMed ID: 16232181
[TBL] [Abstract][Full Text] [Related]
12. Worldwide prevalence estimates of lower urinary tract symptoms, overactive bladder, urinary incontinence and bladder outlet obstruction.
Irwin DE; Kopp ZS; Agatep B; Milsom I; Abrams P
BJU Int; 2011 Oct; 108(7):1132-8. PubMed ID: 21231991
[TBL] [Abstract][Full Text] [Related]
13. Assessment of lower urinary tract symptoms in men by international prostate symptom score and core lower urinary tract symptom score.
Fujimura T; Kume H; Nishimatsu H; Sugihara T; Nomiya A; Tsurumaki Y; Miyazaki H; Suzuki M; Fukuhara H; Enomoto Y; Homma Y
BJU Int; 2012 May; 109(10):1512-6. PubMed ID: 21883834
[TBL] [Abstract][Full Text] [Related]
14. Short- and long-term efficacy of solifenacin treatment in patients with symptoms of mixed urinary incontinence.
Staskin DR; Te AE
BJU Int; 2006 Jun; 97(6):1256-61. PubMed ID: 16686722
[TBL] [Abstract][Full Text] [Related]
15. Nighttime dosing with tolterodine reduces overactive bladder-related nocturnal micturitions in patients with overactive bladder and nocturia.
Rackley R; Weiss JP; Rovner ES; Wang JT; Guan Z;
Urology; 2006 Apr; 67(4):731-6; discussion 736. PubMed ID: 16618562
[TBL] [Abstract][Full Text] [Related]
16. Impact of overactive bladder symptoms on employment, social interactions and emotional well-being in six European countries.
Irwin DE; Milsom I; Kopp Z; Abrams P; Cardozo L
BJU Int; 2006 Jan; 97(1):96-100. PubMed ID: 16336336
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of bladder dysfunction in Parkinsons disease.
Winge K; Skau AM; Stimpel H; Nielsen KK; Werdelin L
Neurourol Urodyn; 2006; 25(2):116-22. PubMed ID: 16402391
[TBL] [Abstract][Full Text] [Related]
18. A population study of nocturia in Singapore.
Liew LC; Tiong HY; Wong ML; Png DC; Tan JK
BJU Int; 2006 Jan; 97(1):109-12. PubMed ID: 16336338
[TBL] [Abstract][Full Text] [Related]
19. Is nocturia equally common among men and women? A population based study in Finland.
Tikkinen KA; Tammela TL; Huhtala H; Auvinen A
J Urol; 2006 Feb; 175(2):596-600. PubMed ID: 16407003
[TBL] [Abstract][Full Text] [Related]
20. The prevalence of overactive bladder and nocturnal enuresis in Japanese early adolescents: a questionnaire survey.
Kajiwara M; Inoue K; Mutaguchi K; Usui T
Hinyokika Kiyo; 2006 Feb; 52(2):107-11. PubMed ID: 16541763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
